Cervicovaginal vascular endothelial growth factor (VEGF) and risk of preterm birth (PTB)

Katherine Campbell, Catalin Buhimschi, Unzila Ali, Guomao Zhao, Asif Ahmed, Irina Buhimschi

Research output: Contribution to journalMeeting abstract

Abstract

Objective - During pregnancy, the human cervix undergoes angiogenic transformations. VEGF is expressed in cervical stroma and is proposed to play key roles in the process of cervical ripening and dilation. This study was conducted to evaluate whether cervical secretion of VEGF can be of clinical value in predicting impending PTB.

Study Design - In an observational prospective cohort study, we analyzed cervical fluid samples from 103 pregnant women (GA: median [IQR]: 28 [25-31] wks) who presented for either a routine prenatal visit (n=61) or for evaluation of threatened preterm labor (n=42). Cervical secretions were collected under a standard protocol which was followed in all cases. Cervical length (CL) was assessed by transvaginal ultrasound using well-established criteria. Dilation was evaluated by digital exam performed only after collection of the biological samples. VEGF levels were immunoassayed by investigators unaware of the clinical outcome. Main exclusion criteria were ruptured membranes, active labor, vaginal bleeding, vaginal exam or intercourse within 24h. Results were analyzed with and without normalization for total protein.

Results - 1) Clinical characteristics of the cohort are presented in Table;2) VEGF was detectable in all specimens, with no correlation between its levels, CL, twins or GA at collection; 3) There was an inverse correlation between VEGF and cervical dilation (R=-0.646, P=0.003); 4) Women with cervical dilation =1 cm had lower VEGF compared to those with a closed cervix (P=0.003); 5) Women who experienced PTB within 14 days (n=11) had lower VEGF (P=0.003); 6) A free VEGF level of =600 pg/mL had a sensitivity, specificity, +LR and -LR of 70%, 95%, 13.5 and 0.3, respectively in predicting PTB within 14 days.

Conclusions - Low VEGF levels in the cervicovaginal secretions of pregnant women are associated with an increased risk of PTB within 2 weeks of collection. Active engagement of VEGF in the process of cervical ripening and dilatation and/or increased affinity of extracellular matrix components for VEGF may provide explanation for our findings.
Original languageEnglish
Article number500
Pages (from-to)S200-S201
Number of pages2
JournalAmerican Journal of Obstetrics and Gynecology
Volume204
Issue numberSuppl.1
DOIs
Publication statusPublished - Jan 2011
Event31st Annual Meeting Society for Maternal-Fetal Medicine - San Francisco, CA, United States
Duration: 7 Feb 201112 Feb 2011

Fingerprint

Premature Birth
Vascular Endothelial Growth Factor A
Dilatation
Cervical Ripening
Cervix Uteri
Pregnant Women
First Labor Stage
Gynecological Examination
Uterine Hemorrhage
Premature Obstetric Labor
Extracellular Matrix
Cohort Studies
Research Personnel
Prospective Studies
Sensitivity and Specificity
Pregnancy

Cite this

Campbell, Katherine ; Buhimschi, Catalin ; Ali, Unzila ; Zhao, Guomao ; Ahmed, Asif ; Buhimschi, Irina. / Cervicovaginal vascular endothelial growth factor (VEGF) and risk of preterm birth (PTB). In: American Journal of Obstetrics and Gynecology. 2011 ; Vol. 204, No. Suppl.1. pp. S200-S201.
@article{c94e2cbf37354938ac173678fcbef228,
title = "Cervicovaginal vascular endothelial growth factor (VEGF) and risk of preterm birth (PTB)",
abstract = "Objective - During pregnancy, the human cervix undergoes angiogenic transformations. VEGF is expressed in cervical stroma and is proposed to play key roles in the process of cervical ripening and dilation. This study was conducted to evaluate whether cervical secretion of VEGF can be of clinical value in predicting impending PTB.Study Design - In an observational prospective cohort study, we analyzed cervical fluid samples from 103 pregnant women (GA: median [IQR]: 28 [25-31] wks) who presented for either a routine prenatal visit (n=61) or for evaluation of threatened preterm labor (n=42). Cervical secretions were collected under a standard protocol which was followed in all cases. Cervical length (CL) was assessed by transvaginal ultrasound using well-established criteria. Dilation was evaluated by digital exam performed only after collection of the biological samples. VEGF levels were immunoassayed by investigators unaware of the clinical outcome. Main exclusion criteria were ruptured membranes, active labor, vaginal bleeding, vaginal exam or intercourse within 24h. Results were analyzed with and without normalization for total protein.Results - 1) Clinical characteristics of the cohort are presented in Table;2) VEGF was detectable in all specimens, with no correlation between its levels, CL, twins or GA at collection; 3) There was an inverse correlation between VEGF and cervical dilation (R=-0.646, P=0.003); 4) Women with cervical dilation =1 cm had lower VEGF compared to those with a closed cervix (P=0.003); 5) Women who experienced PTB within 14 days (n=11) had lower VEGF (P=0.003); 6) A free VEGF level of =600 pg/mL had a sensitivity, specificity, +LR and -LR of 70{\%}, 95{\%}, 13.5 and 0.3, respectively in predicting PTB within 14 days.Conclusions - Low VEGF levels in the cervicovaginal secretions of pregnant women are associated with an increased risk of PTB within 2 weeks of collection. Active engagement of VEGF in the process of cervical ripening and dilatation and/or increased affinity of extracellular matrix components for VEGF may provide explanation for our findings.",
author = "Katherine Campbell and Catalin Buhimschi and Unzila Ali and Guomao Zhao and Asif Ahmed and Irina Buhimschi",
year = "2011",
month = "1",
doi = "10.1016/j.ajog.2010.10.519",
language = "English",
volume = "204",
pages = "S200--S201",
journal = "American Journal of Obstetrics and Gynecology",
issn = "0002-9378",
publisher = "Elsevier",
number = "Suppl.1",

}

Cervicovaginal vascular endothelial growth factor (VEGF) and risk of preterm birth (PTB). / Campbell, Katherine; Buhimschi, Catalin; Ali, Unzila; Zhao, Guomao; Ahmed, Asif; Buhimschi, Irina.

In: American Journal of Obstetrics and Gynecology, Vol. 204, No. Suppl.1, 500, 01.2011, p. S200-S201.

Research output: Contribution to journalMeeting abstract

TY - JOUR

T1 - Cervicovaginal vascular endothelial growth factor (VEGF) and risk of preterm birth (PTB)

AU - Campbell, Katherine

AU - Buhimschi, Catalin

AU - Ali, Unzila

AU - Zhao, Guomao

AU - Ahmed, Asif

AU - Buhimschi, Irina

PY - 2011/1

Y1 - 2011/1

N2 - Objective - During pregnancy, the human cervix undergoes angiogenic transformations. VEGF is expressed in cervical stroma and is proposed to play key roles in the process of cervical ripening and dilation. This study was conducted to evaluate whether cervical secretion of VEGF can be of clinical value in predicting impending PTB.Study Design - In an observational prospective cohort study, we analyzed cervical fluid samples from 103 pregnant women (GA: median [IQR]: 28 [25-31] wks) who presented for either a routine prenatal visit (n=61) or for evaluation of threatened preterm labor (n=42). Cervical secretions were collected under a standard protocol which was followed in all cases. Cervical length (CL) was assessed by transvaginal ultrasound using well-established criteria. Dilation was evaluated by digital exam performed only after collection of the biological samples. VEGF levels were immunoassayed by investigators unaware of the clinical outcome. Main exclusion criteria were ruptured membranes, active labor, vaginal bleeding, vaginal exam or intercourse within 24h. Results were analyzed with and without normalization for total protein.Results - 1) Clinical characteristics of the cohort are presented in Table;2) VEGF was detectable in all specimens, with no correlation between its levels, CL, twins or GA at collection; 3) There was an inverse correlation between VEGF and cervical dilation (R=-0.646, P=0.003); 4) Women with cervical dilation =1 cm had lower VEGF compared to those with a closed cervix (P=0.003); 5) Women who experienced PTB within 14 days (n=11) had lower VEGF (P=0.003); 6) A free VEGF level of =600 pg/mL had a sensitivity, specificity, +LR and -LR of 70%, 95%, 13.5 and 0.3, respectively in predicting PTB within 14 days.Conclusions - Low VEGF levels in the cervicovaginal secretions of pregnant women are associated with an increased risk of PTB within 2 weeks of collection. Active engagement of VEGF in the process of cervical ripening and dilatation and/or increased affinity of extracellular matrix components for VEGF may provide explanation for our findings.

AB - Objective - During pregnancy, the human cervix undergoes angiogenic transformations. VEGF is expressed in cervical stroma and is proposed to play key roles in the process of cervical ripening and dilation. This study was conducted to evaluate whether cervical secretion of VEGF can be of clinical value in predicting impending PTB.Study Design - In an observational prospective cohort study, we analyzed cervical fluid samples from 103 pregnant women (GA: median [IQR]: 28 [25-31] wks) who presented for either a routine prenatal visit (n=61) or for evaluation of threatened preterm labor (n=42). Cervical secretions were collected under a standard protocol which was followed in all cases. Cervical length (CL) was assessed by transvaginal ultrasound using well-established criteria. Dilation was evaluated by digital exam performed only after collection of the biological samples. VEGF levels were immunoassayed by investigators unaware of the clinical outcome. Main exclusion criteria were ruptured membranes, active labor, vaginal bleeding, vaginal exam or intercourse within 24h. Results were analyzed with and without normalization for total protein.Results - 1) Clinical characteristics of the cohort are presented in Table;2) VEGF was detectable in all specimens, with no correlation between its levels, CL, twins or GA at collection; 3) There was an inverse correlation between VEGF and cervical dilation (R=-0.646, P=0.003); 4) Women with cervical dilation =1 cm had lower VEGF compared to those with a closed cervix (P=0.003); 5) Women who experienced PTB within 14 days (n=11) had lower VEGF (P=0.003); 6) A free VEGF level of =600 pg/mL had a sensitivity, specificity, +LR and -LR of 70%, 95%, 13.5 and 0.3, respectively in predicting PTB within 14 days.Conclusions - Low VEGF levels in the cervicovaginal secretions of pregnant women are associated with an increased risk of PTB within 2 weeks of collection. Active engagement of VEGF in the process of cervical ripening and dilatation and/or increased affinity of extracellular matrix components for VEGF may provide explanation for our findings.

U2 - 10.1016/j.ajog.2010.10.519

DO - 10.1016/j.ajog.2010.10.519

M3 - Meeting abstract

VL - 204

SP - S200-S201

JO - American Journal of Obstetrics and Gynecology

JF - American Journal of Obstetrics and Gynecology

SN - 0002-9378

IS - Suppl.1

M1 - 500

ER -